Abstract
According to the World Health Organization (WHO) the number of smokers in the world was estimated to be 1. 1 billion in the year 2000. Of those, 300 million lived in the developed world, while 800 million lived in developing countries.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847–852.
Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL, and the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347–1360.
http://www.who.int/tobacco/en/atlas40.pdf (2002).
Edwards R. The problem of tobacco smoking. BMJ 2004;328:217–219.
Maziak W, Hense HW, Döring A, Keil U. Ten-year trends in smoking behaviour among adults in southern Germany. Int J Tuberc Lung Dis 2002;6:824–830.
Schönherr E. Beitrag zur Statistik und Klinik der Lungentumoren. Z Krebsforsch 1928;27:436–450.
Doll R, Peto R. Mortality in relation to smoking: 20 years’ observations on male British doctors. BMJ 1976;2:1525–1536.
Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 1994;309:901–911.
Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observation on male British doctors. BMJ 2004;328:1529–1537.
Conroy RM, Pyörälä K, Fitzgerald AP, et al., on behalf of the SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003.
Yusuf S, Hawken S, Öunpuu S, et al., on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937–952.
Keil U, Liese AD, Hense HW, et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984–1992. Eur Heart J 1998;19:1197–1207.
Magnus P, Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: time to end the “only-50%” myth. Arch Intern Med 2001;161:2657–2660.
Kromhout D, Menotti A, Blackburn H (eds). Prevention of Coronary Heart Disease. Diet, Lifestyle and Risk Factors in the Seven Countries Study. Dordrecht: Kluwer Academic Publishers; 2002.
Keys A. Seven Countries. A multivariate analysis of death and coronary heart disease. Cambridge, MA: Harvard University Press; 1980:151.
Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997;315:973–980.
He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease — a meta-analysis of epidemiologic studies. N Engl J Med 1999;340:920–926.
Thun M, Henley J, Apicella LF. Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking. Environ Health Perspect 1999;107(suppl):841–846.
Davis RM. Passive smoking: history repeats itself. BMJ 1997;315:961–962.
Keil U, Becher H, Heidrich J, et al. Passivrauchbedingte Morbidität und Mortalität in Deutschland. In: Rote Reihe DKFZ. Die Gefahren der Passivrauchexposition in Deutschland, Heidelberg: Deutsches Krebsforschungszentrum; 2005.
McNeill A. Tobacco use and effects on health. In: Tobacco or Health in the European Union. Luxembourg: European Communities; 2004:40.
Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction. Meta-analysis of cohort studies. Arch Intern Med 2000;160:939–944.
EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Eur Heart J 2001;22:554–572.
Heidrich J, Behrens T, Raspe F, Keil U. Knowledge and perception of guidelines and secondary prevention of coronary heart disease among general practitioners and internists. Results from a physician survey in Germany. Eur J Cardiovasc Prev Rehabil 2005;12(6):521–529.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag London Limited
About this chapter
Cite this chapter
Keil, U. (2007). The Burden of Smoking on Cardiovascular Disease. In: Perk, J., et al. Cardiovascular Prevention and Rehabilitation. Springer, London. https://doi.org/10.1007/978-1-84628-502-8_27
Download citation
DOI: https://doi.org/10.1007/978-1-84628-502-8_27
Publisher Name: Springer, London
Print ISBN: 978-1-84628-462-5
Online ISBN: 978-1-84628-502-8
eBook Packages: MedicineMedicine (R0)